ZOLL Respicardia, Inc. Registry Study
Research payments
$149,437
Through program year 2025, $149,437 in research payments was reported against ZOLL Respicardia, Inc. Registry Study, across 87 payments, paid by Respicardia, Inc..
- Paid by
- Respicardia, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $54,452 | 22 |
| 2024 | Research | $43,281 | 25 |
| 2023 | Research | $32,612 | 27 |
| 2022 | Research | $19,091 | 13 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Parag Kale Dallas, TX Named on 13 payments
- Andrew Zadeh West Hollywood, CA Named on 13 payments
- Michael Drucker Winston Salem, NC Named on 12 payments
- Timothy Morgenthaler Rochester, MN Named on 6 payments
- Nancy Collop Atlanta, GA Named on 5 payments
- John Boehmer Hershey, PA Named on 5 payments
- John Bailey Charlotte, NC Named on 4 payments
- Gaurav Upadhyay Chicago, IL Named on 3 payments
- Mark Neagle Fort Collins, CO Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.